Enzyme vs Celestia — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Celestia trades at Rp7,236 (market cap Rp6,65T, Rp616M 24h volume). The key difference: Celestia is far larger — about 49578.8× Enzyme's market cap, and Enzyme's circulating supply is 3,3M MLN versus 919,9M TIA for Celestia. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Celestia for 47 Days on average.
| MLN | TIA | |
|---|---|---|
Market Cap | Rp134,13M | Rp6,65T |
Volume (24h) | Rp104,56M | Rp616M |
Circulating Supply | 3,3M MLN | 919,9M TIA |
Typical Hold Time | 28 Days | 47 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Celestia (TIA) is currently trading at Rp7,498 with a market cap of Rp6.9 trillion, showing a bullish technical signal driven by strong moving average alignment. Key indicators like RSI_6 at 73.64 suggest mild overbought conditions, while ADX readings above 37 confirm a strong trend. Support and resistance levels are well-defined, with immediate resistance at Rp7,516. No major protocol updates or ecosystem news were reported recently, keeping fundamental developments neutral.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include overbought RSI and crypto market volatility. Key opportunities lie in potential breakout above resistance, while major risks involve regulatory uncertainty and liquidity fluctuations. Investors should monitor volume trends and broader market sentiment.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Celestia (TIA) is the first modular blockchain network that enables anyone to easily deploy their own blockchain with minimal overhead. Celestia scales by rethinking blockchain architecture from the ground up. It is a minimal blockchain that decouples execution from consensus by introducing a new primitive, data availability sampling.
Read more on TIA →